Central nervous system disease in langerhans cell histiocytosis

Histiocytic Disorders of Children and Adults

Volumn , Issue , 2005, Pages 208-228

  Grois, Nicole ^a   Helmut, Prosch ^a   Hans, Lassmann ^b   Daniela, Prayer ^c  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c University Clinic for Radiology   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928283932     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545252.012     Document Type: Chapter

References (75)

1. Ahmed, I., Donadieu, J., Barthez, M.A., et al. (2004). Retinoic acid therapy in degenerative-like neuro-Langerhans cell histiocytosis: a prospective pilot study. Pediatr Blood Cancer,43,55-58.
2. Barthez, M.A., Araujo, E. and Donadieu, J. (2000). Langerhans cell histiocytosis and the central nervous system in childhood: evolution and prognostic factors. Results of a collaborative study. J Child Neurol,15, 150-156.
3. Benmoussa, H., Belghmaidi, M., Tamehmacht, M., et al. (1992). Tuberculoma of pineal area: case report. NeurosurgRev,15, 71-72.
4. Breidahl, W.H., Ives, FJ. and Khangure, M.S. (1993). Cerebral and brain stem Langerhans cell histiocytosis. Neuroradiology,35, 349-351.
5. Broadbent, V. and Pritchard, J. (1997). Diabetes insipidus associated with Langerhans cell histiocytosis: is it reversible? Med Pediatr Oncol,28, 289-293.
6. Brunberg, J.A. (1996). Hyperintense basal ganglia on T1-weighted MR in a patient with Langerhans cell histiocytosis. Am J Neuroradiol,17, 1193-1194.
7. Burn, D.J., Watson, J.D., Roddie, M., et al. (1992). Langerhans’ cell histiocytosis and the nervous system. J Neurol,239, 345-350.
8. Ceci, A., De Terlizzi, M., Colella, R., et al. (1988). Etoposide in recurrent childhood Langerhans’ cell histiocytosis: an Italian cooperative study. Cancer,62,2528-2531.
9. Cerda-Nicolas, M., Broseta, J., Peydro-Olaya, A., et al. (1980). Primary eosinophilic granuloma of the frontal lobe. Virchows Arch A Pathol Anat Histopathol, 388, 221-228.
10. Chester, W. and Kugel, V.H. (1932). Lipoidgranulomatosis (Type, Hand-Schuller-Christian): report of a case. Arch Pathol,14, 595-612.
11. Chiari, H. (1933). Uber Veranderungen im Zentralnervensystem bei generalisierter Xantho- matose von Typus Schuller-Christian. Virchows Arch A Pathol Pathol Anat,288.
12. Christian, H.A. (1920). Defects in membranous bones, exophthalmos and diabetes insipidus; an unusual syndrome of dyspituitarism: a clinical study. Med Clin North Am,3, 849-871.
13. Czernichow, P., Garel, C. and Leger, J. (2000). Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. Horm Res,53(Suppl 3), 61-64.
14. Davison, C. (1933). Xanthomatosis and the central nervous system (Schuller-Christian Syndrome). Arch Neurol,30, 75-98.
15. Dean, H.J., Bishop, A. and Winter, J.S. (1986). Growth hormone deficiency in patients with histiocytosis X. JPediatr,109, 615-618.
16. Dodek, A.B. and Sadeghi-Nejad, A. (1998). Pineal germinoma presenting as central diabetes insipidus. Clin Pediatr (Phila),37, 693-695.
17. Donadieu, J., Rolon, M.A., Thomas, C., et al. (2004). Endocrine involvement in pediatric-onset Langerhans’ cell histiocytosis: a population-based study. J Pediatr,144, 344-350.
18. Dunger, D.B., Broadbent, V., Yeoman, E., et al. (1989). The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis. New Engl J Med,321, 1157-1162.
19. Favara, B.E. and Jaffe, R. (1994). The histopathology of Langerhans cell histiocytosis. Br J Cancer Suppl,23, S17-S23.
20. Feigin, I. (1956). Xanthomatosis of the nervous system. J Neuropathol Exp Neurol,15, 400-416.
21. Gadner, H., Heitger, A., Ritter, J., et al. (1987). Langerhans cell histiocytosis in childhood - results of the DAL-HX 83 study. Klin Padiatr,199, 173-182.
22. Gadner, H., Heitger, A., Grois, N., et al. (1994). Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol,23, 72-80.
23. Giona, F., Annino, L., Bongarzoni, V., et al. (2002). Unifocal Langerhans’ cell histiocytosis involving the central nervous system successfully treated with 2-chlorodeoxyadenosine. Med Pediatr Oncol,38, 223.
24. Gizewski, E.R. and Forsting, M. (2001). Histiocytosis mimicking a pineal gland tumour. Neuroradiology,43, 644-646.
25. Goldberg, R., Han, J.S., Ganz, E., et al. (1987). Computed tomography demonstration of multiple parenchymal central nervous system nodules due to histiocytosis X. Surg Neurol,27, 377-380.
26. Graif, M. and Pennock, J.M. (1986). MR imaging of histiocytosis X in the central nervous system. Am J Neuroradiol,7, 21-23.
27. Greenberger, J.S., Cassady, J.R., Jaffe, N., et al. (1979). Radiation therapy in patients with histiocytosis: management of diabetes insipidus and bone lesions. Int J Radiat Oncol Biol Phys,5,1749-1755.
28. Greenwood, S.M., Martin, J.S. and Towfighi, J. (1981). Unifocal eosinophilic granuloma of the temporal lobe. Surg Neurol,17,441-444.
29. Grois, N., Barkovich, A.J., Rosenau, W., et al. (1993). Central nervous system disease associated with Langerhans’ cell histiocytosis. Am J Pediatr Hematol Oncol,15,245-254.
30. Grois, N., Flucher-Wolfram, B., Heitger, A., et al. (1995). Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study. Med Pediatr Oncol,24, 248-256.
31. Grois, N.G., Favara, B.E., Mostbeck, G.H., et al. (1998). Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am,12, 287-305.
32. Grois, N., Prayer, D., Prosch, H., et al. (2004). Course of diabetes insipidus in Langerhans cell histiocytosis and clinical impact of associated magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis. Pediatr Blood Cancer,43, 59-65.
33. Grois, N., Prayer, H., Prosch, H. and Lassmann, H. (2005). Neuropathology of Central Nervous System Disease in Langerhans Cell Histiocytosis. Brain, in press.
34. Guillemin, G.J. and Brew, B.J. (2004). Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol,75, 388-397.
35. Hand, A. (1921). Defects of membraneous bones, exophthalmos and polyuria in childhood: is it dyspituitarism? Am J Med Sci,162, 509-515.
36. Haupt, R., Nanduri, V., Calevo, M.G., et al. (2004). Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society - Late Effects Study Group. Pediatr Blood Cancer,42,438-444.
37. Howell, S.J, Wilton, P. and Shalet, S.M. (1998). Growth hormone replacement in patients with Langerhans cell histiocytosis. Arch Dis Child,78, 469-473.
38. Kaltsas, G.A., Powles, T.B., Evanson, J., et al. (2000). Hypothalamo-pituitary abnormalities in adult patients with Langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab,85, 1370-1376.
39. Kepes, J.J. (1979). Histiocytosis X. In: Vinken, PJ. and Brujn, G.W., eds. In Handbook of Neurology, Vol. 38. Elsevier Publishing Company, New York, pp. 93-117.
40. Kurtzke, J.F. (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology,33, 1444-1452.
41. LCH CNS Study Group of the Histiocyte Society (2003). LCH CNS 2003 - Registry And Diagnostic Guidelines for Central Nervous System Disease in Langerhans Cell Histiocytosis. Protocol.
42. LCH Study Group of the Histiocyte Society (2001). LCH III - Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis. Protocol.
43. Maghnie, M. (2003). Diabetes insipidus. Horm Res,59(Suppl 1), 42-54.
44. Maghnie, M., Bossi, G., Klersy, C., et al. (1998). Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood Langerhans cell histiocytosis. J Clin Endocrinol Metab,83, 3089-3094.
45. Martin, N., Debroucker, T., Mompoint, D., et al. (1989). Sarcoidosis of the pineal region: CT and MR studies. J Comput Assist Tomogr,13, 110-112.
46. Mazal, P.R., Hainfellner, J.A., Preiser, J., et al. (1996). Langerhans cell histiocytosis of the hypothalamus: diagnostic value of immunohistochemistry. Clin Neuropathol,15, 87-91.
47. Minehan, K.J., Chen, M.G., Zimmerman, D., et al. (1992). Radiation therapy for diabetes insipidus caused by Langerhans cell histiocytosis. Int J Radiat Oncol Biol Phys,23, 519-524.
48. Moscinski, L.C. and Kleinschmidt-DeMasters, B.K. (1985). Primary eosinophilic granuloma of frontal lobe. Diagnostic use of S-100 protein. Cancer,56,284-288.
49. Nanduri, V.R., Bareille, P., Pritchard, J., et al. (2000). Growth and endocrine disorders in multisystem Langerhans’ cell histiocytosis. Clin Endocrinol (Oxf),53, 509-515.
50. Nanduri, V.R., Lillywhite, L., Chapman, C., et al. (2003). Cognitive outcome of long-term survivors of multisystem Langerhans cell histiocytosis: a single-institution, cross-sectional study. J Clin Oncol,21,2961-2967.
51. O’Sullivan, R.M., Sheehan, M., Poskitt, K.J., et al. (1991). Langerhans cell histiocytosis of hypothalamus and optic chiasm: CT and MR studies. J Comput Assist Tomogr,15, 52-55.
52. Ottaviano, F. and Finlay, J.L. (2003). Diabetes insipidus and Langerhans cell histiocytosis: a case report of reversibility with 2-chlorodeoxyadenosine. J Pediatr Hematol Oncol,25, 575-577.
53. Pardanani, A., Phyliky, R.L., Li, C.Y., et al. (2003). 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clin Proc,78, 301-306.
54. Poe, L.B., Dubowy, R.L., Hochhauser, L., et al. (1994). Demyelinating and gliotic cerebellar lesions in Langerhans cell histiocytosis. Am J Neuroradiol,15, 1921-1928.
55. Prayer, D., Grois, N., Prosch, H., et al. (2004). MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. Am J Neuroradiol,25, 880-891.
56. Prosch, H., Grois, N., Prayer, D. et al. (2004). Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatr Blood Cancer,43, 594-599.
57. Ransom, J.L. and Murphy, S.B. (1977). Histiocytosis X: abnormal cerebrospinal fluid cytology in extrahypothalamic central nervous system involvement. South Med J,70, 1367-1369.
58. Rosenzweig, K.E., Arceci, R.J. and Tarbell, N.J. (1997). Diabetes insipidus secondary to Langerhans’ cell histiocytosis: is radiation therapy indicated? Med Pediatr Oncol,29, 36-40.
59. Rubens-Duval, A., Lapresle, J., Fardeau, M., et al. (1966). Neural determinations of Hand- Schuller-Christian disease: Study of an anatomo-clinical case. Sem Hop,42, 1425-1439.
60. Saatci, I., Baskan, O., Haliloglu, M., et al. (1999). Cerebellar and basal ganglion involvement in Langerhans cell histiocytosis. Neuroradiology,41,443-446.
61. Scherbaum, W.A., Wass, J.A., Besser, G.M., et al. (1986). Autoimmune cranial diabetes insipidus: its association with other endocrine diseases and with histiocytosis X. Clin Endocrinol (Oxf), 25,411-420.
62. Schueller, A. (1915). Uber eigenartige Schadeldefekte im Jugendalter. Fortschr Geb Rontgenstr, 23, 12-19.
63. Simms, S. and Warner, N.J. (1998). A framework for understanding and responding to the psychosocial needs of children with Langerhans cell histiocytosis and their families. Hematol Oncol Clin North Am,12, 359-367.
64. Sims, D.G. (1977). Histiocytosis X: follow-up of 43 cases. Arch Dis Child,52,433-440.
65. Tabarin, A., Corcuff, J.B., Dautheribes, M., et al. (1991). Histiocytosis X of the hypothalamus. J Endocrinol Invest,14, 139-145.
66. The French Langerhans’ Cell Histiocytosis Study Group (1996). A multicentre retrospective survey of Langerhans’ cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child,75, 17-24.
67. Tien, R., Kucharczyk, J. and Kucharczyk, W. (1991). MR imaging of the brain in patients with diabetes insipidus. Am J Neuroradiol,12, 533-542.
68. Titgemeyer, C., Grois, N., Minkov, M., et al. (2001). Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Med Pediatr Oncol, 37, 108-114.
69. Trouillas, P., Takayanagi, T., Hallett, M., et al. (1997). International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci,145, 205-211.
70. Wall, M.J., Peyster, R.G., Finkelstein, S.D., et al. (1985). A unique case of neurosarcoidosis with pineal and suprasellar involvement: CT and pathological demonstration. J Comput Assist Tomogr, 9, 381-383.
71. Watts, J. and Files, B. (2001). Langerhans cell histiocytosis: central nervous system involvement treated successfully with 2-chlorodeoxyadenosine. Pediatr Hematol Oncol,18, 199-204.
72. Weller, R.O., Engelhardt, B. and Phillips, M.J. (1996). Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol,6,275-288.
73. Whelan, H.T., Clinton, M.E., Fogo, A., et al. (1987). Histiocytosis-X isolated to the cervical spinal cord. Am JPediatr Hematol Oncol,9, 228-232.
74. Willis, B., Ablin, A., Weinberg, V., et al. (1996). Disease course and late sequelae of Langerhans’ cell histiocytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol,14, 2073-2082.
75. Woo, K.I. and Harris, G.J. (2003). Eosinophilic granuloma of the orbit: understanding the paradox of aggressive destruction responsive to minimal intervention. Ophthal Plast Reconstr Surg, 19, 429-439.